- Home
- CBFV vs HUMA Comparison
CBFV vs HUMA Comparison
Compare CBFV & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CBFV | HUMA |
|---|---|---|
| Founded | 1901 | 2004 |
| Country | United States | United States |
| Employees | N/A | 184 |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 184.7M | 191.4M |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | CBFV | HUMA |
|---|---|---|
| Price | $36.27 | $0.66 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 8 |
| Target Price | ★ $38.00 | $6.19 |
| AVG Volume (30 Days) | 6.8K | ★ 18.0M |
| Earning Date | 04-22-2026 | 05-15-2026 |
| Dividend Yield | ★ 3.12% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.73 | N/A |
| Revenue | ★ $43,557,000.00 | N/A |
| Revenue This Year | $48.93 | $444.16 |
| Revenue Next Year | $7.97 | $248.39 |
| P/E Ratio | $50.71 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $27.80 | $0.55 |
| 52 Week High | $38.86 | $2.84 |
Technical Indicators
Market Signals| Indicator | CBFV | HUMA |
|---|---|---|
| Relative Strength Index (RSI) | 46.63 | 36.22 |
| Support Level | $34.06 | $0.65 |
| Resistance Level | $36.44 | $1.26 |
| Average True Range (ATR) | 0.73 | 0.07 |
| MACD | -0.22 | 0.00 |
| Stochastic Oscillator | 17.26 | 10.91 |
Price Performance
Historical ComparisonAbout CBFV CB Financial Services Inc.
CB Financial Services Incis a bank holding company headquartered in Carmichaels, Pennsylvania. The company had one reportable segment, community banking services. The Bank also has a loan production office in Allegheny County, a loan production office and a corporate center in Washington County, and an operations center in Greene County, Pennsylvania. The Bank is a community-oriented institution offering residential and commercial real estate loans, commercial and industrial loans, and consumer loans, as well as a variety of deposit products for individuals and businesses in its market area.
About HUMA Humacyte Inc.
Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.